Richard Jay Smeyne, Ph.D. - Publications

Affiliations: 
1996-2016 Developmental Neurobiology St Jude Children's Research Hospital, New York, NY, United States 
 2106- Neuroscience Thomas Jefferson University 
Area:
Parkinson's Disease

114 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Smeyne RJ, Eells JB, Chatterjee D, Byrne M, Akula SM, Sriramula S, O'Rourke DP, Schmidt P. COVID-19 infection enhances susceptibility to oxidative-stress induced parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35579496 DOI: 10.1002/mds.29116  0.568
2022 Kozina E, Byrne M, Smeyne RJ. Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson's disease. Npj Parkinson's Disease. 8: 24. PMID 35292674 DOI: 10.1038/s41531-022-00289-9  0.795
2022 Rocha SM, Bantle CM, Aboellail T, Chatterjee D, Smeyne RJ, Tjalkens RB. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice. Neurobiology of Disease. 167: 105685. PMID 35257879 DOI: 10.1016/j.nbd.2022.105685  0.308
2021 Bantle CM, Rocha SM, French CT, Phillips AT, Tran K, Olson KE, Bass TA, Aboellail T, Smeyne RJ, Tjalkens RB. Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis. Experimental Neurology. 346: 113845. PMID 34454938 DOI: 10.1016/j.expneurol.2021.113845  0.311
2021 Oakes HV, McWethy D, Ketchem S, Tran L, Phillips K, Oakley L, Smeyne RJ, Pond BB. Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism. Neurotoxicity Research. PMID 33666887 DOI: 10.1007/s12640-021-00347-9  0.613
2020 Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Infection and Risk of Parkinson's Disease. Journal of Parkinson's Disease. PMID 33361610 DOI: 10.3233/JPD-202279  0.61
2020 Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, Al-Dalahmah O, Zecca L, Sette A, Bubacco L, Meucci O, Moro E, Harms AS, Xu Y, Fahn S, et al. COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. Npj Parkinson's Disease. 6: 18. PMID 32885037 DOI: 10.1038/S41531-020-00123-0  0.39
2019 Bantle CM, Phillips AT, Smeyne RJ, Rocha SM, Olson KE, Tjalkens RB. Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation. Npj Parkinson's Disease. 5: 20. PMID 31531390 DOI: 10.1038/S41531-019-0090-8  0.414
2019 Merlino DJ, Barton JR, Charsar BA, Byrne MD, Rappaport JA, Smeyne RJ, Lepore AC, Snook AE, Waldman SA. Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin. Brain Structure & Function. PMID 31485718 DOI: 10.1007/S00429-019-01949-Y  0.336
2018 Yang J, Simonneau C, Kilker R, Oakley L, Byrne MD, Nichtova Z, Stefanescu I, Pardeep-Kumar F, Tripathi S, Londin E, Saugier-Veber P, Willard B, Thakur M, Pickup S, Ishikawa H, ... ... Smeyne R, et al. Murine -linked hydrocephalus is caused by hyperpermeability of the choroid plexus. Embo Molecular Medicine. PMID 30518636 DOI: 10.15252/Emmm.201809540  0.65
2018 Kozina E, Sadasivan S, Jiao Y, Dou Y, Ma Z, Tan H, Kodali K, Shaw T, Peng J, Smeyne RJ. Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. Brain : a Journal of Neurology. 141: 1753-1769. PMID 29800472 DOI: 10.1093/Brain/Awy077  0.794
2017 Sadasivan S, Sharp B, Schultz-Cherry S, Smeyne RJ. Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis. Npj Parkinson's Disease. 3: 18. PMID 28649618 DOI: 10.1038/S41531-017-0019-Z  0.574
2016 Smeyne RJ, Breckenridge CB, Beck M, Jiao Y, Butt MT, Wolf JC, Zadory D, Minnema DJ, Sturgess NC, Travis KZ, Cook AR, Smith LL, Botham PA. Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice. Plos One. 11: e0164094. PMID 27788145 DOI: 10.1371/Journal.Pone.0164094  0.411
2016 Humann J, Mann B, Gao G, Moresco P, Ramahi J, Loh LN, Farr A, Hu Y, Durick-Eder K, Fillon SA, Smeyne RJ, Tuomanen EI. Bacterial Peptidoglycan Transverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior. Cell Host & Microbe. 19: 388-99. PMID 26962947 DOI: 10.1016/J.Chom.2016.02.009  0.321
2015 Gingras S, Earls LR, Howell S, Smeyne RJ, Zakharenko SS, Pelletier S. SCYL2 Protects CA3 Pyramidal Neurons from Excitotoxicity during Functional Maturation of the Mouse Hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 10510-22. PMID 26203146 DOI: 10.1523/Jneurosci.2056-14.2015  0.404
2015 Sadasivan S, Zanin M, O'Brien K, Schultz-Cherry S, Smeyne RJ. Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus. Plos One. 10: e0124047. PMID 25861024 DOI: 10.1371/Journal.Pone.0124047  0.565
2015 Smeyne M, Sladen P, Jiao Y, Dragatsis I, Smeyne RJ. HIF1α is necessary for exercise-induced neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta. Neuroscience. 295: 23-38. PMID 25796140 DOI: 10.1016/J.Neuroscience.2015.03.015  0.381
2015 Jiao Y, Dou Y, Lockwood G, Pani A, Smeyne RJ. Acute Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or Paraquat on Core Temperature in C57BL/6J Mice. Journal of Parkinson's Disease. PMID 25633843 DOI: 10.3233/Jpd-140424  0.339
2014 Tian J, Tep C, Benedick A, Saidi N, Ryu JC, Kim ML, Sadasivan S, Oberdick J, Smeyne R, Zhu MX, Yoon SO. p75 regulates Purkinje cell firing by modulating SK channel activity through Rac1. The Journal of Biological Chemistry. 289: 31458-72. PMID 25253694 DOI: 10.1074/Jbc.M114.589937  0.666
2014 Pani AK, Jiao Y, Sample KJ, Smeyne RJ. Neurochemical measurement of adenosine in discrete brain regions of five strains of inbred mice. Plos One. 9: e92422. PMID 24642754 DOI: 10.1371/Journal.Pone.0092422  0.324
2014 Zigmond MJ, Smeyne RJ. Exercise: is it a neuroprotective and if so, how does it work? Parkinsonism & Related Disorders. 20: S123-7. PMID 24262162 DOI: 10.1016/S1353-8020(13)70030-0  0.566
2014 Jackson-Lewis V, Lester D, Kozina E, Przedborski S, Smeyne RJ. From Man to Mouse: The MPTP Model of Parkinson Disease Movement Disorders: Genetics and Models: Second Edition. 287-306. DOI: 10.1016/B978-0-12-405195-9.00017-2  0.544
2013 Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radical Biology & Medicine. 62: 13-25. PMID 23665395 DOI: 10.1016/J.Freeradbiomed.2013.05.001  0.332
2012 Adeosun SO, Hou X, Jiao Y, Zheng B, Henry S, Hill R, He Z, Pani A, Kyle P, Ou X, Mosley T, Farley JM, Stockmeier C, Paul I, Bigler S, ... ... Smeyne R, et al. Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease. Plos One. 7: e50040. PMID 23209637 DOI: 10.1371/Journal.Pone.0050040  0.415
2012 Gerecke KM, Jiao Y, Pagala V, Smeyne RJ. Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice. Plos One. 7: e43250. PMID 22912838 DOI: 10.1371/Journal.Pone.0043250  0.744
2012 Heyer MP, Pani AK, Smeyne RJ, Kenny PJ, Feng G. Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 10887-94. PMID 22875923 DOI: 10.1523/Jneurosci.1732-12.2012  0.33
2012 Pattarini R, Rong Y, Shepherd KR, Jiao Y, Qu C, Smeyne RJ, Morgan JI. Long-lasting transcriptional refractoriness triggered by a single exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine. Neuroscience. 214: 84-105. PMID 22542874 DOI: 10.1016/J.Neuroscience.2012.03.047  0.799
2012 Sadasivan S, Pond BB, Pani AK, Qu C, Jiao Y, Smeyne RJ. Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice. Plos One. 7: e33693. PMID 22470460 DOI: 10.1371/Journal.Pone.0033693  0.645
2012 Jang H, Boltz D, McClaren J, Pani AK, Smeyne M, Korff A, Webster R, Smeyne RJ. Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1545-59. PMID 22302798 DOI: 10.1523/Jneurosci.5123-11.2012  0.776
2012 Jiao Y, Lu L, Williams RW, Smeyne RJ. Genetic dissection of strain dependent paraquat-induced neurodegeneration in the substantia nigra pars compacta. Plos One. 7: e29447. PMID 22291891 DOI: 10.1371/Journal.Pone.0029447  0.415
2012 Zigmond MJ, Cameron JL, Hoffer BJ, Smeyne RJ. Neurorestoration by physical exercise: moving forward. Parkinsonism & Related Disorders. 18: S147-50. PMID 22166417 DOI: 10.1016/S1353-8020(11)70046-3  0.636
2012 Sadasivan S, Pond BB, Pani AK, Qu C, Jiao Y, Smeyne RJ. Correction: Methylphenidate Exposure Induces Dopamine Neuron Loss and Activation of Microglia in the Basal Ganglia of Mice Plos One. 7. DOI: 10.1371/annotation/c76da2c1-ccb8-4797-94c1-359d3ceceeda  0.637
2012 Adeosun S, Hou X, Jiao Y, Zheng B, Kyle P, Paul I, Farley J, Stockmeier C, Bigler S, Smeyne R, Wang J. 3.243 INCREASING ENDOGENOUS NEUROGENESIS USING NEUROSTEROIDS: A NOVEL THERAPEUTIC STRATEGY TO TREAT PARKINSON'S DISEASE Parkinsonism & Related Disorders. 18: S214. DOI: 10.1016/S1353-8020(11)70915-4  0.326
2012 Korff A, Pfeiffer B, Smeyne M, Kocak M, Pfeiffer R, Smeyne R. 2.130 CHANGE IN GLUTATHIONE-S-TRANSFERASE-PI EXPRESSION IN BLOOD OF PARKINSON'S DISEASE PATIENTS FOLLOWING EXPOSURE TO OXIDATIVE STRESS: POTENTIAL USE AS A BIOMARKER Parkinsonism & Related Disorders. 18: S109. DOI: 10.1016/S1353-8020(11)70502-8  0.661
2011 McEvoy J, Flores-Otero J, Zhang J, Nemeth K, Brennan R, Bradley C, Krafcik F, Rodriguez-Galindo C, Wilson M, Xiong S, Lozano G, Sage J, Fu L, Louhibi L, Trimarchi J, ... ... Smeyne R, et al. Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. Cancer Cell. 20: 260-75. PMID 21840489 DOI: 10.1016/J.Ccr.2011.07.005  0.347
2011 Korff A, Pfeiffer B, Smeyne M, Kocak M, Pfeiffer RF, Smeyne RJ. Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients. Parkinsonism & Related Disorders. 17: 765-8. PMID 21840241 DOI: 10.1016/J.Parkreldis.2011.06.026  0.689
2010 Lloyd SA, Balest ZR, Corotto FS, Smeyne RJ. Cocaine selectively increases proliferation in the adult murine hippocampus. Neuroscience Letters. 485: 112-6. PMID 20817079 DOI: 10.1016/J.Neulet.2010.08.080  0.575
2010 Henry J, Smeyne RJ, Jang H, Miller B, Okun MS. Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries. Parkinsonism & Related Disorders. 16: 566-71. PMID 20650672 DOI: 10.1016/J.Parkreldis.2010.06.012  0.509
2010 Zigmond M, Smeyne RJ. Foreword: exercise and the brain. Brain Research. 1341: 1-2. PMID 20538145 DOI: 10.1016/J.Brainres.2010.05.053  0.499
2010 Burton AR, Baquet Z, Eisenbarth GS, Tisch R, Smeyne R, Workman CJ, Vignali DA. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 4863-70. PMID 20348424 DOI: 10.4049/Jimmunol.0903728  0.776
2010 Gerecke KM, Jiao Y, Pani A, Pagala V, Smeyne RJ. Exercise protects against MPTP-induced neurotoxicity in mice. Brain Research. 1341: 72-83. PMID 20116369 DOI: 10.1016/J.Brainres.2010.01.053  0.755
2010 Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, Bruneau BG, Giasson BI, Smeyne RJ, Gershon MD, Nussbaum RL. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Human Molecular Genetics. 19: 1633-50. PMID 20106867 DOI: 10.1093/Hmg/Ddq038  0.37
2009 Zigmond MJ, Cameron JL, Leak RK, Mirnics K, Russell VA, Smeyne RJ, Smith AD. Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism & Related Disorders. 15: S42-5. PMID 20083005 DOI: 10.1016/S1353-8020(09)70778-3  0.582
2009 Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y, Webster R, Smeyne RJ. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America. 106: 14063-8. PMID 19667183 DOI: 10.1073/Pnas.0900096106  0.761
2009 Baquet ZC, Williams D, Brody J, Smeyne RJ. A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse. Neuroscience. 161: 1082-90. PMID 19376196 DOI: 10.1016/J.Neuroscience.2009.04.031  0.786
2009 Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proceedings of the National Academy of Sciences of the United States of America. 106: 2933-8. PMID 19196989 DOI: 10.1073/Pnas.0813361106  0.433
2009 Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochimica Et Biophysica Acta. 1792: 714-21. PMID 18760350 DOI: 10.1016/j.bbadis.2008.08.001  0.469
2009 Jang H, Boltz D, Ramirez K, Shephard K, Jiao Y, Webster R, Smeyne R. P3.067 Mice infected with highly pathogenic H5N1 influenza virus develop Parkinsonian pathology Parkinsonism & Related Disorders. 15: S165. DOI: 10.1016/S1353-8020(09)70631-5  0.508
2009 Jiao Y, Pani A, Hopper J, Griner J, Smeyne R. P2.011 Effect of aging on SNpc neuron loss, striatal dopamine and genea expression in C57BL/6 and Swiss-Webster mice following MPTP administration Parkinsonism & Related Disorders. 15: S91. DOI: 10.1016/S1353-8020(09)70362-1  0.391
2009 Sadasivan S, Jiao Y, Pani A, Pond B, Alele P, Smeyne R. P1.006 Neurochemical and neuroplastic changes in chronic methyphenidate administered brains Parkinsonism & Related Disorders. 15: S30. DOI: 10.1016/S1353-8020(09)70128-2  0.669
2008 Holst J, Wang H, Eder KD, Workman CJ, Boyd KL, Baquet Z, Singh H, Forbes K, Chruscinski A, Smeyne R, van Oers NS, Utz PJ, Vignali DA. Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity. Nature Immunology. 9: 658-66. PMID 18469818 DOI: 10.1038/Ni.1611  0.771
2007 Wei P, Smeyne RJ, Bao D, Parris J, Morgan JI. Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons. The European Journal of Neuroscience. 26: 2962-78. PMID 18001291 DOI: 10.1111/J.1460-9568.2007.05913.X  0.606
2007 Boyd JD, Jang H, Shepherd KR, Faherty C, Slack S, Jiao Y, Smeyne RJ. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta. Brain Research. 1175: 107-16. PMID 17884023 DOI: 10.1016/J.Brainres.2007.07.067  0.789
2007 Smeyne M, Boyd J, Shepherd KR, Jiao Y, Pond BB, Hatler M, Wolf R, Henderson C, Smeyne RJ. GSTπ expression mediates dopaminergic neuron sensitivity in experimental parkinsonism Proceedings of the National Academy of Sciences of the United States of America. 104: 1977-1982. PMID 17267597 DOI: 10.1073/Pnas.0610978104  0.793
2007 Pattarini R, Smeyne RJ, Morgan JI. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease. Neuroscience. 145: 654-68. PMID 17258864 DOI: 10.1016/J.Neuroscience.2006.12.030  0.614
2007 Baquet Z, Pani A, Dodgen L, Griner J, Jiao Y, Smeyne R. 2.454 The immunosuppressant, 4-deoxypyridoxine (DOP), demonstrates novel neuroprotective effects in the acute MPTP model of Parkinson's disease Parkinsonism & Related Disorders. 13: S142. DOI: 10.1016/S1353-8020(08)70774-0  0.776
2007 Smeyne M, Jiao Y, Griner J, Jang H, Smeyne R. 2.428 VEGF and angiogenesis in an animal model of Parkinson's disease Parkinsonism & Related Disorders. 13: S135. DOI: 10.1016/S1353-8020(08)70748-X  0.503
2007 Smeyne R, Jang H, Boltz D, Sturm-Ramirez K, Webster R. 2.410 Is H5N1 influenza virus a novel etiological agent in the development of post-encephalitic parkinsonism? Parkinsonism & Related Disorders. 13: S130. DOI: 10.1016/S1353-8020(08)70730-2  0.482
2006 Lloyd SA, Faherty CJ, Smeyne RJ. Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 137: 905-13. PMID 16298078 DOI: 10.1016/J.Neuroscience.2005.09.035  0.771
2006 Smeyne RJ, Chu T, Lewin A, Bian F, Sanlioglu S, Kunsch C, Lira SA, Oberdick J. Corrigendum to "Local control of granule cell generation by cerebellar purkinje cells" [Mol. Cell. Neurosci. 6 (1995) 230-251] (DOI:10.1006/j.mcn.1995.10.019) Molecular and Cellular Neuroscience. 32: 215. DOI: 10.1016/J.Mcn.2006.04.001  0.651
2005 Johnson DK, Rinchik EM, Moustaid-Moussa N, Miller DR, Williams RW, Michaud EJ, Jablonski MM, Elberger A, Hamre K, Smeyne R, Chesler E, Goldowitz D. Phenotype screening for genetically determined age-onset disorders and increased longevity in ENU-mutagenized mice. Age (Dordrecht, Netherlands). 27: 75-90. PMID 23598606 DOI: 10.1007/S11357-005-4131-3  0.553
2005 Smeyne M, Jiao Y, Shepherd KR, Smeyne RJ. Glia cell number modulates sensitivity to MPTP in mice. Glia. 52: 144-52. PMID 15920722 DOI: 10.1002/Glia.20233  0.79
2005 Jackson-Lewis V, Smeyne RJ. MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview. Neurotoxicity Research. 7: 193-202. PMID 15897154 DOI: 10.1007/Bf03036449  0.37
2005 Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Brain Research. Molecular Brain Research. 134: 170-9. PMID 15790541 DOI: 10.1016/J.Molbrainres.2004.08.008  0.749
2005 Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson's disease. Brain Research. Molecular Brain Research. 134: 57-66. PMID 15790530 DOI: 10.1016/J.Molbrainres.2004.09.017  0.402
2004 Lewis PM, Gritli-Linde A, Smeyne R, Kottmann A, McMahon AP. Sonic hedgehog signaling is required for expansion of granule neuron precursors and patterning of the mouse cerebellum. Developmental Biology. 270: 393-410. PMID 15183722 DOI: 10.1016/J.Ydbio.2004.03.007  0.378
2004 Jensen P, Smeyne R, Goldowitz D. Analysis of cerebellar development in math1 null embryos and chimeras. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 2202-11. PMID 14999071 DOI: 10.1523/Jneurosci.3427-03.2004  0.714
2003 Lloyd SA, Wensley B, Faherty CJ, Smeyne RJ. Regional differences in cortical dendrite morphology following in utero exposure to cocaine. Brain Research. Developmental Brain Research. 147: 59-66. PMID 14741751 DOI: 10.1016/J.Devbrainres.2003.09.008  0.764
2003 Faherty CJ, Kerley D, Smeyne RJ. A Golgi-Cox morphological analysis of neuronal changes induced by environmental enrichment. Brain Research. Developmental Brain Research. 141: 55-61. PMID 12644248 DOI: 10.1016/S0165-3806(02)00642-9  0.747
2003 Cook R, Lu L, Gu J, Williams RW, Smeyne RJ. Identification of a single QTL, Mptp1, for susceptibility to MPTP-induced substantia nigra pars compacta neuron loss in mice. Brain Research. Molecular Brain Research. 110: 279-88. PMID 12591164 DOI: 10.1016/S0169-328X(02)00659-9  0.409
2002 Smeyne M, Smeyne RJ. Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease. Brain Research. Brain Research Protocols. 9: 105-11. PMID 12034329 DOI: 10.1016/S1385-299X(02)00117-4  0.382
2002 Leimig T, Mann L, Martin Mdel P, Bonten E, Persons D, Knowles J, Allay JA, Cunningham J, Nienhuis AW, Smeyne R, d'Azzo A. Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood. 99: 3169-78. PMID 11964280 DOI: 10.1182/Blood.V99.9.3169  0.364
2002 Cunningham JJ, Levine EM, Zindy F, Goloubeva O, Roussel MF, Smeyne RJ. The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit. Molecular and Cellular Neurosciences. 19: 359-74. PMID 11906209 DOI: 10.1006/Mcne.2001.1090  0.571
2002 McKeller RN, Fowler JL, Cunningham JJ, Warner N, Smeyne RJ, Zindy F, Skapek SX. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proceedings of the National Academy of Sciences of the United States of America. 99: 3848-53. PMID 11891301 DOI: 10.1073/Pnas.052484199  0.535
2001 Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, Eberhart CG, Burger PC, Baker SJ. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nature Genetics. 29: 404-11. PMID 11726927 DOI: 10.1038/Ng781  0.392
2001 Smeyne M, Goloubeva O, Smeyne RJ. Strain-dependent susceptibility to MPTP and MPP(+)-induced parkinsonism is determined by glia. Glia. 34: 73-80. PMID 11307156 DOI: 10.1002/Glia.1042  0.415
2000 Chen SC, Cunningham JJ, Smeyne RJ. Expression of OB receptor splice variants during prenatal development of the mouse. Journal of Receptor and Signal Transduction Research. 20: 87-103. PMID 10711499 DOI: 10.3109/10799890009150039  0.528
1999 Zindy F, Cunningham JJ, Sherr CJ, Jogal S, Smeyne RJ, Roussel MF. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proceedings of the National Academy of Sciences of the United States of America. 96: 13462-7. PMID 10557343 DOI: 10.1073/Pnas.96.23.13462  0.621
1999 Faherty CJ, Xanthoudakis S, Smeyne RJ. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Brain Research. Molecular Brain Research. 70: 159-63. PMID 10381555 DOI: 10.1016/S0169-328X(99)00143-6  0.714
1999 Hamre K, Tharp R, Poon K, Xiong X, Smeyne RJ. Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus. Brain Research. 828: 91-103. PMID 10320728 DOI: 10.1016/S0006-8993(99)01273-1  0.377
1998 Rottier RJ, Hahn CN, Mann LW, del Pilar Martin M, Smeyne RJ, Suzuki K, d'Azzo A. Lack of PPCA expression only partially coincides with lysosomal storage in galactosialidosis mice: indirect evidence for spatial requirement of the catalytic rather than the protective function of PPCA. Human Molecular Genetics. 7: 1787-94. PMID 9736781 DOI: 10.1093/Hmg/7.11.1787  0.387
1998 Rice FL, Albers KM, Davis BM, Silos-Santiago I, Wilkinson GA, LeMaster AM, Ernfors P, Smeyne RJ, Aldskogius H, Phillips HS, Barbacid M, DeChiara TM, Yancopoulos GD, Dunne CE, Fundin BT. Differential dependency of unmyelinated and A delta epidermal and upper dermal innervation on neurotrophins, trk receptors, and p75LNGFR. Developmental Biology. 198: 57-81. PMID 9640332 DOI: 10.1006/Dbio.1998.8861  0.311
1997 Morgan JI, Smeyne RJ. Transgenic approaches to cerebellar development. Perspectives On Developmental Neurobiology. 5: 33-41. PMID 9509516  0.487
1997 Chen SC, Ehrhard P, Goldowitz D, Smeyne RJ. Developmental expression of the GIRK family of inward rectifying potassium channels: implications for abnormalities in the weaver mutant mouse. Brain Research. 778: 251-64. PMID 9459542 DOI: 10.1016/S0006-8993(97)00896-2  0.568
1997 Persons DA, Allay JA, Allay ER, Smeyne RJ, Ashmun RA, Sorrentino BP, Nienhuis AW. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood. 90: 1777-86. PMID 9292510 DOI: 10.1182/Blood.V90.5.1777  0.313
1997 Vassileva G, Smeyne RJ, Morgan JI. Absence of neuroanatomical and behavioral deficits in L7/pcp-2-null mice. Brain Research. Molecular Brain Research. 46: 333-7. PMID 9191112 DOI: 10.1016/S0169-328X(97)00081-8  0.572
1996 Paradies MA, Grishkat H, Smeyne RJ, Oberdick J, Morgan JI, Eisenman LM. Correspondence between L7-lacZ-expressing Purkinje cells and labeled olivocerebellar fibers during late embryogenesis in the mouse. The Journal of Comparative Neurology. 374: 451-66. PMID 8906510 DOI: 10.1002/(Sici)1096-9861(19961021)374:3<451::Aid-Cne9>3.0.Co;2-0  0.716
1996 Fagan AM, Zhang H, Landis S, Smeyne RJ, Silos-Santiago I, Barbacid M. TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 6208-18. PMID 8815902 DOI: 10.1523/Jneurosci.16-19-06208.1996  0.507
1996 Kasof GM, Smeyne RJ, Curran T, Morgan JI. Developmental expression of Fos-lacZ in the brains of postnatal transgenic rats. Brain Research. Developmental Brain Research. 93: 191-7. PMID 8804706 DOI: 10.1016/0165-3806(96)00005-3  0.571
1996 Xanthoudakis S, Smeyne RJ, Wallace JD, Curran T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proceedings of the National Academy of Sciences of the United States of America. 93: 8919-23. PMID 8799128 DOI: 10.1073/Pnas.93.17.8919  0.319
1995 Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C, Morgan JI, Curran T. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron. 14: 241-52. PMID 7857636 DOI: 10.1016/0896-6273(95)90282-1  0.53
1995 Silos-Santiago I, Molliver DC, Ozaki S, Smeyne RJ, Fagan AM, Barbacid M, Snider WD. Non-TrkA-expressing small DRG neurons are lost in TrkA deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 5929-42. PMID 7666178 DOI: 10.1523/Jneurosci.15-09-05929.1995  0.528
1995 Goldowitz D, Smeyne RJ. Tune into the weaver channel. Nature Genetics. 11: 107-9. PMID 7550328 DOI: 10.1038/Ng1095-107  0.472
1995 Smeyne RJ, Chu T, Lewin A, Bian F, Sanlioglu S, S-Crisman S, Kunsch C, Lira SA, Oberdick J. Local control of granule cell generation by cerebellar Purkinje cells. Molecular and Cellular Neurosciences. 6: 230-51. PMID 7496629 DOI: 10.1006/Mcne.1995.1019  0.677
1994 Lamballe F, Smeyne RJ, Barbacid M. Developmental expression of trkC, the neurotrophin-3 receptor, in the mammalian nervous system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 14-28. PMID 8283230 DOI: 10.1523/Jneurosci.14-01-00014.1994  0.32
1994 Klein R, Silos-Santiago I, Smeyne RJ, Lira SA, Brambilla R, Bryant S, Zhang L, Snider WD, Barbacid M. Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature. 368: 249-51. PMID 8145824 DOI: 10.1038/368249A0  0.318
1994 Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature. 368: 246-9. PMID 8145823 DOI: 10.1038/368246A0  0.368
1994 Miao GG, Smeyne RJ, D'Arcangelo G, Copeland NG, Jenkins NA, Morgan JI, Curran T. Isolation of an allele of reeler by insertional mutagenesis. Proceedings of the National Academy of Sciences of the United States of America. 91: 11050-4. PMID 7972007 DOI: 10.1073/Pnas.91.23.11050  0.545
1994 Fagan AM, Barbacid M, Smeyne RJ. The role of nerve growth factor family receptors in the development of the mammalian nervous system European Neuropsychopharmacology. 4: 226. DOI: 10.1016/0924-977X(94)90054-X  0.415
1993 Molinar-Rode R, Smeyne RJ, Curran T, Morgan JI. Regulation of proto-oncogene expression in adult and developing lungs. Molecular and Cellular Biology. 13: 3213-20. PMID 8497249 DOI: 10.1128/Mcb.13.6.3213  0.548
1993 Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363: 166-9. PMID 8483500 DOI: 10.1038/363166A0  0.647
1993 Smeyne RJ, Schilling K, Oberdick J, Robertson L, Luk D, Curran T, Morgan JI. A fos-lac Z transgenic mouse that can be used for neuroanatomic mapping. Advances in Neurology. 59: 285-91. PMID 8420113  0.76
1993 Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL, Barbacid M. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell. 75: 113-22. PMID 8402890 DOI: 10.1016/S0092-8674(05)80088-1  0.35
1993 Oberdick J, Schilling K, Smeyne RJ, Corbin JG, Bocchiaro C, Morgan JI. Control of segment-like patterns of gene expression in the mouse cerebellum. Neuron. 10: 1007-18. PMID 8318226 DOI: 10.1016/0896-6273(93)90050-2  0.759
1993 Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI. Correction: Continuous c- fos expression precedes programmed cell death in vivo Nature. 365: 279-279. DOI: 10.1038/365279B0  0.487
1992 Smeyne RJ, Schilling K, Robertson L, Luk D, Oberdick J, Curran T, Morgan JI. fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron. 8: 13-23. PMID 1730004 DOI: 10.1016/0896-6273(92)90105-M  0.777
1992 Smeyne RJ, Curran T, Morgan JI. Temporal and spatial expression of a fos-lacZ transgene in the developing nervous system. Brain Research. Molecular Brain Research. 16: 158-62. PMID 1334194 DOI: 10.1016/0169-328X(92)90206-Q  0.565
1991 Smeyne RJ, Pickford LB, Rouse RV, Napieralski J, Goldowitz D. Abnormalities in premigratory granule cells in the weaver cerebellum defined by monoclonal antibody OZ42. Anatomy and Embryology. 183: 213-9. PMID 2042747 DOI: 10.1007/Bf00192209  0.565
1991 Smeyne RJ, Oberdick J, Schilling K, Berrebi AS, Mugnaini E, Morgan JI. Dynamic organization of developing Purkinje cells revealed by transgene expression. Science (New York, N.Y.). 254: 719-21. PMID 1948052 DOI: 10.1126/Science.1948052  0.778
1990 Smeyne RJ, Goldowitz D. Postnatal development of the wild-type and weaver cerebellum after embryonic administration of propylthiouracil (PTU). Brain Research. Developmental Brain Research. 54: 282-6. PMID 2397591 DOI: 10.1016/0165-3806(90)90151-N  0.569
1990 Smeyne RJ, Goldowitz D. Purkinje cell loss is due to a direct action of the weaver gene in Purkinje cells: evidence from chimeric mice. Brain Research. Developmental Brain Research. 52: 211-8. PMID 2331788 DOI: 10.1016/0165-3806(90)90237-S  0.586
1990 Oberdick J, Smeyne RJ, Mann JR, Zackson S, Morgan JI. A promoter that drives transgene expression in cerebellar Purkinje and retinal bipolar neurons. Science (New York, N.Y.). 248: 223-6. PMID 2109351 DOI: 10.1126/Science.2109351  0.74
1989 Smeyne RJ, Goldowitz D. Development and death of external granular layer cells in the weaver mouse cerebellum: a quantitative study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 1608-20. PMID 2723742 DOI: 10.1523/Jneurosci.09-05-01608.1989  0.585
1989 Reeves RH, Crowley MR, Lorenzon N, Pavan WJ, Smeyne RJ, Goldowitz D. The mouse neurological mutant weaver maps within the region of chromosome 16 that is homologous to human chromosome 21. Genomics. 5: 522-6. PMID 2575584 DOI: 10.1016/0888-7543(89)90018-9  0.51
Show low-probability matches.